Reply to Letter: Spectral-domain optical coherence tomography as a potential biomarker in Huntington's disease
- PMID: 27548531
- DOI: 10.1002/mds.26767
Reply to Letter: Spectral-domain optical coherence tomography as a potential biomarker in Huntington's disease
Comment on
-
Spectral-Domain Optical Coherence Tomography as a Potential Biomarker in Huntington's Disease.Mov Disord. 2016 Mar;31(3):377-83. doi: 10.1002/mds.26486. Epub 2016 Feb 8. Mov Disord. 2016. PMID: 26853218
-
Spectral-domain optical coherence tomography as a potential biomarker in Huntington's disease.Mov Disord. 2016 Nov;31(11):1762. doi: 10.1002/mds.26770. Epub 2016 Sep 13. Mov Disord. 2016. PMID: 27619236 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
